PT-141 (Bremelanotide) is a synthetic peptide analog derived from α-melanocyte-stimulating hormone (α-MSH), specifically designed to activate melanocortin receptors. Laboratory research involving PT-141 examines its potential roles in sexual behavior, libido modulation, and central nervous system signaling pathways. Studies indicate PT-141 may influence sexual function and arousal through direct action on melanocortin receptors within the brain.
Scientific investigations continue to explore PT-141’s potential impacts on sexual motivation, erectile function, and neuroendocrine responses within controlled laboratory environments.
Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of PT-141 outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).
Product Specifications:
- Purity: ≥99% (HPLC verified)
- Formulation: Lyophilized powder
- Molecular Formula: C50H68N14O10
- Molecular Weight: 1025.2 g/mol
- CAS Number: 189691-06-3
Source: PubChem